Zydus Lifesciences plans ₹5,000 crore QIP for debt and M&A
pre-market1 source ↓written by the desknot a recommendation
- to bolster
- ₹5,000 crore QIP
Zydus Lifesciences is set to launch a ₹5,000 crore QIP to bolster its balance sheet and pursue strategic acquisitions. The funds will help reduce existing debt and support long-term growth initiatives. Three investment banks, including Jefferies and JP Morgan, have been appointed as advisors for this capital raise. 📈
Not investment advice. For informational purposes only.